Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$400,000.00
Jan 1, 2020
For-profit organization
Development of Cannabis and Nutraceutical infused QuickStrip Products
935556
Rapid Dose Therapeutics Corp. (RDT) is a publicly traded Canadian life science company (CSE: DOSE) that develops innovative, proprietary drug delivery technologies designed to improve health and wellness outcomes and improve quality of life.
$24,500.00
Jun 17, 2019
For-profit organization
YEP - Design and development of novel biopolymer compositions for oral dispersible thin films for enhanced mucosal delivery and rapid uptake of medicinal active agents.
931323
QuickStrip™ is a proprietary oral thin film delivery method developed by Rapid Dose Therapeutics, which is designed for rapid uptake of therapeutic ingredients directly into the bloodstream. The film consists of micronized active ingredient that is evenly dispersed throughout a rapidly dissolving film matrix. The goals of this project are to optimize the current QuickStrip™ formulation, as well as develop new product formulations in respond to customer needs and new market opportunities in both human health and animal health applications.